Literature DB >> 23095863

Novel developments in the mechanisms of immune tolerance to allergens.

Thomas Eiwegger1, Saskia Gruber, Zsolt Szépfalusi, Cezmi A Akdis.   

Abstract

Allergy is the result of a disbalanced immune response to environmental innocuous antigens. Despite of accumulating data to define the pathomechanisms that take place in case of allergic diseases a detailed understanding of sequence of events that lead to the "normal" scenario of tolerance development are still under debate. Allergen-specific immunotherapy is the only causal treatment of allergic diseases. It modifies the immune response to a particular antigen to achieve tolerance against the symptom-causing allergen. This process is considered to mirror physiological peripheral tolerance induction. A number of immunological changes have been described to occur under allergen immunotherapy, including the generation of allergen-specific regulatory T cells, the induction of allergen-specific IgG4, an increase in the Th1/Th2 cytokine ratio and decreased activation and function of effector cells such as mast cells, basophils and eosinophils.

Entities:  

Keywords:  T-cells; allergen-specific immunotherapy; allergy; tolerance

Mesh:

Substances:

Year:  2012        PMID: 23095863      PMCID: PMC3660770          DOI: 10.4161/hv.20903

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  93 in total

1.  Allergen-specific immunotherapy with recombinant grass pollen allergens.

Authors:  Marek Jutel; Lothar Jaeger; Roland Suck; Hanns Meyer; Helmut Fiebig; Oliver Cromwell
Journal:  J Allergy Clin Immunol       Date:  2005-09       Impact factor: 10.793

2.  Circulating Foxp3+CD4+ cell numbers in atopic patients and healthy control subjects.

Authors:  Kanami Orihara; Masami Narita; Takashi Tobe; Akira Akasawa; Yukihiro Ohya; Kenji Matsumoto; Hirohisa Saito
Journal:  J Allergy Clin Immunol       Date:  2007-07-12       Impact factor: 10.793

3.  Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen.

Authors:  O Akbari; R H DeKruyff; D T Umetsu
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

4.  Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings.

Authors:  P W Ewan; J Deighton; A B Wilson; P J Lachmann
Journal:  Clin Exp Allergy       Date:  1993-08       Impact factor: 5.018

5.  Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.

Authors:  V A Varney; Q A Hamid; M Gaga; S Ying; M Jacobson; A J Frew; A B Kay; S R Durham
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

6.  Early markers for protective mechanisms during rush venom immunotherapy.

Authors:  C Bussmann; J Xia; J-P Allam; L Maintz; T Bieber; N Novak
Journal:  Allergy       Date:  2010-12       Impact factor: 13.146

7.  Inhibition of angiogenesis by IL-32: possible role in asthma.

Authors:  Norbert Meyer; Janine Christoph; Heidi Makrinioti; Philippe Indermitte; Claudio Rhyner; Michael Soyka; Thomas Eiwegger; Maciej Chalubinski; Kerstin Wanke; Hiroyuki Fujita; Paulina Wawrzyniak; Simone Bürgler; Sherrie Zhang; Mübeccel Akdis; Günter Menz; Cezmi Akdis
Journal:  J Allergy Clin Immunol       Date:  2012-02-14       Impact factor: 10.793

8.  Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid.

Authors:  Daniel Mucida; Yunji Park; Gisen Kim; Olga Turovskaya; Iain Scott; Mitchell Kronenberg; Hilde Cheroutre
Journal:  Science       Date:  2007-06-14       Impact factor: 47.728

9.  Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-gamma production of T cells.

Authors:  M Pierkes; I Bellinghausen; T Hultsch; G Metz; J Knop; J Saloga
Journal:  J Allergy Clin Immunol       Date:  1999-02       Impact factor: 10.793

Review 10.  Sublingual immunotherapy for allergic rhinitis.

Authors:  Suzana Radulovic; Moises A Calderon; Duncan Wilson; Stephen Durham
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08
View more
  2 in total

Review 1.  Immunotherapy in allergy and cellular tests: state of art.

Authors:  Salvatore Chirumbolo
Journal:  Hum Vaccin Immunother       Date:  2014-05-02       Impact factor: 3.452

Review 2.  Molecular biomarkers for grass pollen immunotherapy.

Authors:  Florin-Dan Popescu
Journal:  World J Methodol       Date:  2014-03-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.